Viewing Study NCT01170650


Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2026-01-29 @ 6:00 PM
Study NCT ID: NCT01170650
Status: TERMINATED
Last Update Posted: 2021-09-30
First Post: 2010-07-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Sponsor: Endocyte
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None ovarian View
None platinum-resistant View
None Phase III View
None EC145 View
None EC20 View